TSCAN THERAPEUTICS INC (TCRX)

US89854M1018 - Common Stock

8.62  +0.9 (+11.66%)

After market: 8.62 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
21.05M13.54M10.14M1.09M0.00
Operating Expenses
114.51M80.17M58.78M27.32M14.21M
Research and Development
88.15M59.82M44.95M20.58M9.44M
Selling, General, and Administrative Expenses
26.35M20.35M13.83M6.74M4.77M
Operating Income
-93.46M-66.64M-48.64M-26.23M-14.21M
Interest Income/Expense
4.24M420.00K20.00K110.00K550.00K
Income Before Taxes
-89.22M-66.22M-48.63M-26.13M-13.66M
Net Income
-89.22M-66.22M-48.63M-26.13M-13.66M
EBITDA
-88.10M-61.50M-45.31M-25.00M-13.69M
 
Per Share Data
EPS Diluted Total Ops
-1.87-2.75-2.06-1.11-0.58
Non GAAP EPS
-1.89-2.75N/AN/AN/A
 
Statistics
Profit Margin
-423.86%-489.07%-479.59%-2397.25%N/A
Operating Profit Margin
-444.00%-492.17%-479.68%-2406.42%N/A

All data in USD

Charts